ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 25 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $760,000 | -31.5% | 142,000 | 0.0% | 0.01% | -30.0% |
Q3 2016 | $1,110,000 | +37.4% | 142,000 | 0.0% | 0.01% | +25.0% |
Q2 2016 | $808,000 | +35.8% | 142,000 | 0.0% | 0.01% | +33.3% |
Q1 2016 | $595,000 | -38.2% | 142,000 | 0.0% | 0.01% | -25.0% |
Q4 2015 | $963,000 | +16.3% | 142,000 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $828,000 | -24.9% | 142,000 | 0.0% | 0.01% | -20.0% |
Q2 2015 | $1,102,000 | -23.8% | 142,000 | 0.0% | 0.01% | -16.7% |
Q1 2015 | $1,446,000 | – | 142,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |